We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




White Matter Hyperintensities Precede Alzheimer's Onset

By HospiMedica International staff writers
Posted on 20 Apr 2016
A new study suggests that autosomal dominant Alzheimer's disease (AD) is associated with increased white matter hyperintensities (WMH) on magnetic resonance imaging (MRI), evident well before symptom onset.
 
Researchers at Columbia University (New York, NY, USA), Washington University School of Medicine (WUSTL; St. More...
Louis, MO, USA), and other institution participating in the Dominantly Inherited Alzheimer Network (DIAN; St. Louis, MO, USA), conducted a study involving 299 participants (median age 39 years), including 184 who had a mutation that results in AD, and 115 of their first-degree relatives who served as non-carrier controls.
 
The researchers than calculated the estimated years to AD from expected symptom onset by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were also analyzed for total and regional WMH. The researchers found that mutation carriers had greater total WMH volumes, which increased approximately six years prior to expected symptom onset. The effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years prior to estimated onset. The study was published on March 26, 2016, in Annals of Neurology.
 
“Autosomal dominant Alzheimer's disease is associated with increased WMH well before expected symptom onset,” concluded lead author Seonjoo Lee, PhD, of Columbia University, and colleagues. “The findings suggest the possibility that WMH are a core feature of Alzheimer's disease, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease.”
 
The white matter of the brain contains the neuronal fibers that transmit information around the living brain. Historically, the vast majority of neuroscience research effort has been invested in understanding and studying gray matter and neurons, while white matter has received relatively little attention, largely due to the lack of effective research tools to study it, even though it comprises about half the volume of the brain.
 

Related Links: 
 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.